Results 201 to 210 of about 19,814 (246)
Case Report: Beating the assumed prognosis: homozygous familial hypercholesterolemia with unexpected long survival. [PDF]
Zlatohlávek L +4 more
europepmc +1 more source
Efficacy and safety of proprotein convertase subtilisin/kexin type 9 inhibitors for adults with familial hypercholesterolemia: A network meta-analysis. [PDF]
Ding W, Sun L, Shi Y, Tian L.
europepmc +1 more source
Assessment of CoQ10 Dietary Intake in a Mediterranean Cohort of Familial Hypercholesterolemia Patients: A Pilot Study. [PDF]
Sanclemente T +6 more
europepmc +1 more source
Genetic Spectrum of Lithuanian Familial Hypercholesterolemia Patients. [PDF]
Aliosaitiene U +8 more
europepmc +1 more source
Screening for Familial Hypercholesterolemia in Children and its Cost-Effectiveness. [PDF]
Nagahara K.
europepmc +1 more source
Beyond lipids: Systemic effects of lipoprotein apheresis
Transfusion, Volume 66, Issue 3, Page 590-598, March 2026.
Menatalla Nadim, Yamac Akgun
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Heterozygous Familial Hypercholesterolemia
Circulation, 2016Familial hypercholesterolemia (FH) is a genetic condition that causes high low-density lipoprotein (LDL) cholesterol (sometimes referred to as bad cholesterol) from birth. FH means high cholesterol that runs in a family. FH is caused by specific DNA changes that are passed on from parents to their children. It is not caused by lifestyle factors such as
Angela, Onorato, Amy C, Sturm
openaire +2 more sources
Current Treatment Options in Cardiovascular Medicine, 2002
Heterozygous familial hypercholesterolemia is a common, severe form of elevated plasma, low-density lipoprotein (LDL) cholesterol. Familial hypercholesterolemia is under-recognized and under-treated despite well-known benefits from available lipid-lowering medications.
openaire +2 more sources
Heterozygous familial hypercholesterolemia is a common, severe form of elevated plasma, low-density lipoprotein (LDL) cholesterol. Familial hypercholesterolemia is under-recognized and under-treated despite well-known benefits from available lipid-lowering medications.
openaire +2 more sources
Tendon Pathology in Hypercholesterolemia and Familial Hypercholesterolemia
Current Rheumatology Reports, 2017Hypercholesterolemia (HC), or high cholesterol, is usually caused by diet, other health conditions, or inherited diseases, such as familial hypercholesterolemia (FHC). Studies have shown patients with hypercholesterolemia are more prone to tendon injury and impaired healing.
Brittany, Taylor +2 more
openaire +2 more sources

